Subscribe to RSS
DOI: 10.1055/s-0039-1693022
German Heart Surgery Report 2018: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery
Address for correspondence
Publication History
20 May 2019
20 May 2019
Publication Date:
16 July 2019 (online)
Abstract
Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), well-defined data of all cardiac, thoracic, and vascular surgery procedures performed in 78 German heart surgery departments during the year 2018 are analyzed. For this period, a total of 174,902 procedures were submitted to the registry, 98,707 summarized as heart surgery procedures in the classical meaning. The unadjusted in-hospital survival rate for 33,999 isolated coronary artery bypass grafting procedures (relationship on-/off-pump 3.8:1) was 97.1% and for 34,915 isolated heart valve procedures, 14,396 transcatheter interventions included, it was 96.0%. Concerning short- and long-term circulatory supports, a total of 2,871 extracorporeal life support (ECLS)/extracorporeal membrane oxygenation (ECMO) implants, respectively, 942 assist device implantations (L-/R-/BVAD, TAH) were registered. In 2018, the number of isolated heart transplantations increased to 312, a growth of 23% compared with the previous year. The isolated lung transplantations reached 340, a rise of nearly 19%. This annual updated registry of the GSTCVS represents voluntary public reporting by accumulating actual information for nearly all heart surgical procedures in Germany, constitutes advancements in heart medicine, and is a basis for quality management for all participating institutions. In addition, the registry demonstrates that the provision of cardiac surgery in Germany is appropriate and nationwide patient treatment is guaranteed all the time.
#
Keyword
heart valve procedures - heart surgery - mortality - congenital heart disease - coronary heart disease - aorta surgery - coronary artery bypass grafting - heart and lung transplantationIntroduction
Legitimate demands for a sophisticated quality management in medicine—by authorities, scientific organizations, health care companies, and patients all over the world—have stimulated a quality awareness, resulting in the development of versatile quality assurance activities such as benchmark projects, public reporting, registries, and others to answer those needs. Thirty years ago, the board of directors of the German Society for Thoracic and Cardiovascular Surgery (GSTCVS, www.dgthg.de) decided to set up a periodic data collection of all cardiac surgical procedures in terms of a voluntary unaudited registry.[1] [2] Since 1989, the data are updated annually, summarized in sense of a registry, and published in the scientific society journal each year.[3] [4] [5] [6] [7] The prevalent aims are: to detect developments and upcoming trends in cardiac surgery in Germany; to compile various results for nearly all cardiac surgical procedures; to provide each participant with a benchmark of the institutional results to the nationwide achievements; and to facilitate an evaluation on an international level for the German society.
For monitoring actual conditions as well as developments in cardiac medicine, the registry covers all relevant techniques and also innovative technologies, including minimally invasive cardiac surgery and all kinds of heart valve procedures, including transcatheter aortic valve implantation (TAVI). Thereby, important findings for current patient safety and the future of patient care are collected for evaluation under different aspects.
Data and results presented in this report comprehend assorted findings of the year 2018.
#
Materials and Methods
Since 2004, a standardized questionnaire gathers specific information for well-defined procedures exactly described by an annually updated German adaption of the International Classification of Procedures in Medicine called operation code (Operationen- und Prozedurenschlüssel).
All participating institutions were requested to complete the structured questionnaire by January 21, 2019, entering all performed procedures and associated in-hospital mortality. The recommended path for data export is an electronic transmission of an encrypted file to the society office in Berlin. After transaction, the data were decrypted, evaluated for completeness, and compiled for further analysis, thus ensuring anonymity for each participating institution. This compilation algorithm enables a high compliance for submission of complete datasets.
Inclusion criteria for the registry data 2018 were all cardiac surgical procedures performed on patients between January 1, 2018, and December 31, 2018, unrelated to the date of patients' admission or discharge as compared with other registries. Like in the earlier years, the number of procedures was counted rather than individual patients. For example, if a patient initially required isolated coronary artery bypass grafting (CABG), later followed by a mitral valve reconstruction due to an undesirable event, one count in the category “coronary surgery” and a second one in the category “mitral valve reconstruction” are enumerated. Thus, the registry contains more procedures than the real number of patients operated on.
Death of patients was defined as in-hospital mortality. Per definition, the observed mortality is always attributed to the first cardiac procedure, for example, the death of a patient requiring a replacement of the ascending aorta due to a complication after CABG would only be attributed to the coronary procedure.
The main reason for this structural setup of the registry—established over three decades—is to keep in accordance with the German data privacy act with its specific regulations for patients. Furthermore, it seemed to be relevant to get detailed information about all performed procedures and not only the count of treated patients. Last but not least, the process of data acquisition had to be standardized and feasible for all participating departments in Germany, thus enabling the submission of a complete dataset, regardless of the locally existing hard- and software used.
In 2018, a total of 78 institutions performed heart surgery. As always, all departments answered the questionnaire and delivered a complete dataset for the year 2018 including in-hospital mortality rates. In addition, comparisons between the registry data and the external quality assurance in accordance with §§ 135a/136/137 SGB V, obligatory for licensed German hospitals (§ 108 SGB V), are feasible.
For statistical analyses, categorized tables and a summary registry data file consolidate all transmitted information of the 78 departments, providing the basis for this and further publications. Longitudinal data from earlier registry specifications are also included in the presentation. The period considered is restricted to the past 10 years.
Categorical data are displayed as absolute and/or relative frequencies. Due to the lack of complete data for patients' risk adjustment, all mortality rates are unadjusted. Quantitative data are presented as absolute frequencies and arithmetic mean values. Where appropriate, the value range is presented additionally. Patient age, though originally a quantitative variable, is only available in age groups and therefore treated as a categorical variable. German population-based measures are calculated as frequencies per 100,000 inhabitants and are based on the latest published data of the Federal Office for Statistics (Destatis) from November 30, 2018.
The questionnaires were compiled using Microsoft Visual Basic for Applications. Analyses were performed with IBM SPSS Statistics v22 and Microsoft Excel 2010, and charts and tables were created with Microsoft Excel 2010.
#
Registry Data 2018
[Table 1] shows the distribution of cardiac surgical procedures between the 16 German states, based on the population count of the Federal Office for Statistics as of November 30, 2018. The range of heart operations per 100,000 inhabitants again shows a minimum of 102.1 (Baden Württemberg, population: 11,076,352) and a maximum of 165.3 (Sachsen-Anhalt, population: 2,209,938), while the nationwide mean value was 117.9 (2017: 122.0). Analyzing quantified categories of heart operations by department dimension, nearly 67% of institutions are in two clusters with at least 518 up to 1,480 procedures, and 26% in those with a minimum of 1,569 up to a maximum of 3,872 performed procedures ([Table 2]). Summarizing the departments by various heart surgical procedures, it can be asserted that heart operations in patients for congenital heart disease (< 1 year, with extracorporeal circulation [ECC]) are conducted in 22, isolated heart transplantations in 20, and combined heart–lung transplantations in 2 institutions ([Table 3]). The number of procedures using ECC in Germany from 2009 to 2018 is illustrated in [Table 4]. Over the past decade, the number of heart operations using ECC shows a decline by 14,585 procedures, presumably reflecting an achievement of established innovations such as catheter-based procedures in cardiac medicine and minimally invasive therapeutic options in heart surgery.
Federal state |
Quantity[a] |
Population[b] |
Heart procedures/100,000 inhabitants |
---|---|---|---|
Baden Württemberg |
11,306 |
11,076,352 |
102.1 |
Bayern |
13,690 |
13,082,541 |
104.6 |
Berlin |
3,923 |
3,644,998 |
107.6 |
Brandenburg |
3,414 |
2,511,943 |
135.9 |
Bremen |
799 |
682,947 |
117.0 |
Hamburg |
2,232 |
1,841,484 |
121.2 |
Hessen |
7,395 |
6,268,099 |
118.0 |
Mecklenburg-Vorpommern |
2,266 |
1,610,280 |
140.7 |
Niedersachsen |
10,235 |
7,984,849 |
128.2 |
Nordrhein-Westfalen |
20,610 |
17,932,567 |
114.9 |
Rheinland-Pfalz |
5,119 |
4,085,831 |
125.3 |
Saarland |
1,313 |
991,116 |
132.5 |
Sachsen |
5,107 |
4,079,703 |
125.2 |
Sachsen-Anhalt |
3,653 |
2,209,938 |
165.3 |
Schleswig-Holstein |
4,005 |
2,897,035 |
138.2 |
Thüringen |
2,876 |
2,144,446 |
134.1 |
Germany |
97,943 |
83,044,129 |
117.9 |
a n = 764 foreign residents excluded.
b Federal Office for Statistics of German: Population; due date November 30, 2018.
Procedures (quantity) |
<500 |
500–999 |
1,000–1,499 |
1,500–1,999 |
2,000–5,000 |
---|---|---|---|---|---|
Departments |
6 |
25 |
27 |
10 |
10 |
Average |
367 |
789 |
1,190 |
1,750 |
2,716 |
Range |
225–475 |
518–991 |
1,004–1,480 |
1,569–1,941 |
2,023–3,872 |
a Pacemaker/implantable cardioverter–defibrillator and extracardiac surgery without extracorporeal circulation are excluded.
Category |
N |
---|---|
Coronary artery bypass grafting |
77 |
Heart valve surgery |
77 |
Surgery for CHD in pat. <1 y with ECC |
22[a] |
Heart transplantation |
20[b] |
Heart–lung transplantation |
2 |
a N = 2,086: thereof: 6 to 16 operations in 2 units, 25 to 49 operations in 6 units, 58 to 97 operations in 4 units, and 109 to 234 operations in 10 units.
b N = 312: thereof: 1 to 4 transplants in six units, 6 to 9 transplants in three units, 10 to 19 transplants in six units, and 21 to 81 transplants in five units.
Overall, 174,902 procedures were reported to the registry for the year 2018, a decrease of 2.5% (2017: 179,337 procedures). In 2018, a total of 98,707 heart surgical procedures in the narrower sense display a decline of 3.0% (n = 3,021) compared with 2017 (101,728 procedures) ([Table 5]). Concerning gender distribution, the registry shows an overall male:female ratio of 1.9:1 with the greatest distinction (3.3:1) in the patient group of coronary procedures ([Table 6]); 11.3% (n = 11,147) of the operations were conducted as emergency procedures, and 8.8% (n = 8,642) were reoperations ([Table 7]). A total of 16,840 (48.2%) isolated heart valve procedures were performed as single, 3,233 as double (9.3%), and 353 (1.0%) as triple valve procedures ([Table V1]); 7,021 (41.7%) single heart valve operations were performed via a minimally invasive access ([Table V2]). In 8,800 (87.8%) isolated aortic valve operations under ECC conditions, xenograft prostheses were implanted, while in 3,999 (64.3%) isolated mitral valve operations, a reconstruction with preservation of the native valve could be achieved ([Table V3], [Figs. 5] and [7]). The subdivision of 3,586 multiple heart valve procedures led to 3,014 (84.0) operations, as a combination of mitral + tricuspid (n = 1,607) or mitral + aortic (n = 1,407) valve procedures ([Tables V4] and [V5]).
Category |
With ECC |
Without ECC |
Total |
Difference 2017 (%) |
---|---|---|---|---|
Coronary artery bypass grafting |
37,051[a] |
7,219[a] |
44,270 |
−7.1 |
Heart valve procedures |
20,671[a] |
14,244[a] |
34,915 |
+1.5 |
Surgery of thoracic aorta |
7,562[a] |
607[a] |
8,169 |
−0.6 |
Surgery for CHD |
4,882[a] |
971[a] |
5,853 |
−1.0 |
Cardiac surgery, other |
1,119[a] |
1,229[a] |
2,348 |
+6.7 |
Assist device procedures |
656[a] |
2,106[a] |
2,762 |
−5.1 |
Extracardiac surgery |
355[a] |
53,788 |
54,143 |
−1.2 |
Pacemaker and ICD procedures |
35[a] |
22,407 |
22,442 |
−3.3 |
Total |
72,331 |
102,571 |
174,902 |
−2.5 |
a Sum: n = 98,707 (heart surgery procedures).
Procedures with ECC |
2018 |
2017 |
||
---|---|---|---|---|
Emergency |
11,147 |
11.3% |
12,032 |
11.8% |
Redo |
8,642 |
8.8% |
9,049 |
8.9% |
Notes: Transcatheter heart valve procedures: 13,279 aortic valve implantation; 156 mitral valve implantation; 831 mitral valve repair; 3 tricuspid valve implantation; 102 tricuspidal valve repair; 4 pulmonary valve implantation; and 21 combined aortic and mitral valves procedure.
Notes: A total of 3,488 (35%) by partial sternotomy. A total of 3,403 (55%) mitral valve procedures by minimally invasive access. Apical aortic conduit procedures (n = 3) not included.
Note: Transcatheter procedures and apical aortic conduit procedures (n = 3) not included.
Mitral valve procedures |
Repair |
Implantation/replacement |
Total |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
N |
† |
% |
N |
† |
% |
N |
% |
† |
% |
|
Isolated |
3,999 |
49 |
1.2 |
2,223 |
207 |
9.3 |
6,222 |
64.3 |
256 |
4.1 |
CABG |
1,302 |
86 |
6.6 |
903 |
139 |
15.4 |
2,205 |
59.0 |
225 |
10.2 |
Tricuspid valve repair[a] |
918 |
27 |
2.9 |
632 |
71 |
11.2 |
1,550 |
59.2 |
98 |
6.3 |
Aortic valve |
558 |
33 |
5.9 |
849 |
130 |
15.3 |
1,407 |
39.7 |
163 |
11.6 |
CABG + aortic valve replacement |
241 |
25 |
10.4 |
256 |
47 |
18.4 |
497 |
48.5 |
72 |
14.5 |
Total |
7,018 |
220 |
3.1 |
4,863 |
594 |
12.2 |
11,881 |
59.1 |
814 |
6.9 |
a 57 procedures (not specified mitral valve + tricuspid valve surgery) excluded. Mortality: 9% (5/57).
Combinations |
N |
† |
% |
---|---|---|---|
Mitral + tricuspid |
1,607 |
103 |
6.4 |
Aortic + mitral |
1,407 |
163 |
11.6 |
Aortic + mitral + tricuspid |
352 |
47 |
13.4 |
Aortic + tricuspid |
168 |
19 |
11.3 |
Aortic + pulmonary[a] |
37 |
0 |
0.0 |
Tricuspid + pulmonary |
14 |
0 |
0.0 |
Aortic + mitral + pulmonary |
1 |
1 |
100.0 |
Total |
3,586 |
333 |
9.3 |
Note: Transcatheter procedures are excluded.
a Including Ross procedures.
[Tables V6], [C1], [C2], [Con1], [Con2], and [Mis1] to [Mis5] as well as [Figs. 1] [2] [3] [4], [6], [8]–[10] demonstrate further compiled registry data under different aspects and for various categories.
Without ECC |
With ECC |
Total |
|||||
---|---|---|---|---|---|---|---|
N |
† |
N |
† |
N |
† |
% |
|
Aortic valve implantation |
13,190 |
336 |
89 |
22 |
13,279 |
358 |
3 |
Transvascular |
11,582 |
254 |
72 |
18 |
11,654 |
272 |
2 |
Transapical |
1,608 |
82 |
17 |
4 |
1,625 |
86 |
5 |
Mitral valve |
925 |
25 |
62 |
1 |
987 |
26 |
3 |
Repair |
777 |
13 |
54 |
0 |
831 |
13 |
2 |
Implantation |
148 |
12 |
8 |
1 |
156 |
13 |
8 |
Tricuspid valve repair |
105 |
2 |
0 |
0 |
105 |
2 |
2 |
Repair |
102 |
2 |
0 |
0 |
102 |
2 |
2 |
Implantation |
3 |
0 |
0 |
0 |
3 |
0 |
0 |
Aortic + mitral valve implantation |
20 |
2 |
1 |
0 |
21 |
2 |
10 |
Aortic valve implantation[a] + CABG |
23 |
3 |
7 |
2 |
30 |
5 |
17 |
Mitral valve implantation[b] + CABG |
0 |
0 |
7 |
2 |
7 |
2 |
29 |
Aortic + mitral valve + CABG |
0 |
0 |
0 |
0 |
0 |
0 |
– |
Total |
14,263 |
368 |
166 |
27 |
14,429 |
395 |
3 |
Notes: Pulmonary valve implantation for congenital heart disease excluded; 12% of transcatheter aortic valve implantation (TAVI) by transapical access and less than 1% of TAVI under the use of ECC.
a Femoral, subclavian, or transaortic access.
b Transvascular and transapical access.
Transplant |
With ECC |
Without ECC |
||||
---|---|---|---|---|---|---|
N |
† |
% |
N |
† |
% |
|
HTx |
312 |
33 |
10.6 |
|||
HLTx |
2 |
0 |
0.0 |
|||
LTx |
45 |
4 |
8.9 |
295 |
10 |
3.4 |
Notes: All pediatric transplantations (demonstrated in [Table Con2]) are included in this table. Eurotransplant (ET) report 2018: 312 HTx, 4 HTx + kidney Tx, 0 HTx + liver Tx, 2 HLTx, 317 DLTx, 54 SLTx, 0 LTx + kidney Tx, and 2 LTx + liver Tx.
Replacement[a] |
With ECC |
Without ECC |
||||
---|---|---|---|---|---|---|
N |
† |
% |
N |
† |
% |
|
Supracoronary replacement of ascending aorta |
1,308 |
111 |
8.5 |
|||
Supracoronary ascending + aortic valve replacement |
1,308 |
68 |
5.2 |
|||
Infracoronary ascending |
||||||
Mechanical aortic valve conduits |
400 |
22 |
5.5 |
|||
Biological aortic conduits |
1,062 |
113 |
10.6 |
|||
David procedure |
474 |
4 |
0.8 |
|||
Yacoub procedure |
127 |
0 |
0.0 |
|||
Other |
259 |
17 |
6.6 |
|||
Aortic arch replacement[b] |
2,497 |
319 |
12.8 |
|||
Replacement of descending aorta |
44 |
6 |
13.6 |
4 |
0 |
0.0 |
Thoracoabdominal aortic replacement |
81 |
7 |
8.6 |
16 |
3 |
18.8 |
Endostent descending aorta |
2 |
0 |
0.0 |
587 |
32 |
5.5 |
Total |
7,562 |
667 |
8.8 |
607 |
35 |
5.8 |
Notes: All procedures involving aortic surgery are included in this table. Isolated aortic surgery as well as all possible combined procedures (e.g., additional coronary artery bypass grafting) are summarized in this category.
a Procedures for abdominal aortic diseases excluded: 438, abdominal procedures and 18, endovascular abdominal stents.
b All possible combined procedures included; the only common denominator is aortic arch surgery.
Note: A total of 279 procedures are unspecified with regard to endocardiac/epicardiac ablation.
Compared with the data of previous years, several important developments remained almost unchanged in 2018. The age distribution of patients ([Fig. 3]) shows a continuous shift toward an elderly patient population, with presently 34.8% of the cardiac procedures being performed in patients from 70 to 79 years of age, and 17.6% in octo-/nonagenarians. However, unadjusted mortality rates remain on the same low level over the past decade ([Fig. 2]). The number of CABG procedures, isolated or combined, decreased over the past decade, while the relative count for isolated off-pump CABG has now reached a level of 20.6% (2017: 19.4%) ([Figs. 1] and [4]).
There is still a continuous increase of transcatheter heart valve procedures in Germany ([Table V6]). In 2018, a total of 13,279 (57.5%) TAVI procedures and 9,829 (42.5%) surgical aortic valve replacements were reported to the registry ([Fig. 6]). It must be emphasized that exclusively the German departments for cardiac surgery contribute their data and therefore the registry cannot reach completeness by the way of exception. On the basis of and in addition to the recommendations of international scientific guidelines resp. expert consensus on the management of valvular heart disease,[8] [9] [10] [11] in July 2015, the German Federal Joint Committee (G-BA) implemented a quality assurance directive for “minimally invasive heart valve interventions (TAVI, transcatheter mitral clip reconstruction),” in which obligatory structures, defined processes, and qualified personnel are precisely specified.[12] Further surveys for selected procedures, such as the legally compulsory quality assurance (§135a SGB V) or the voluntary nationwide German Aortic Valve Registry,[13] [14] [15] [16] [17] [18] provide various important findings and thus contribute to an exceptional patient benefit.
In 2018, the rate of mitral valve reconstructions shows a slight increase to 64.3% (2017: 63.7%) ([Fig. 7]). Based on the fact that each isolated mitral valve procedure is included, regardless of the underlying valve disease concerning morphology or urgency of operation, it can be assumed that the relative rate of mitral valve reconstruction would certainly be even higher if patients without a possibility or indication for reconstruction would have been excluded (e.g., mitral valve stenosis, calcifications, or endocarditis). In other publications, for example, Gammie et al,[19] patients with mitral valve stenosis, endocarditis, and emergency procedures are usually excluded. Therefore, the published rates of mitral valve repair have to be interpreted with caution if compared with this registry.
In 2018, the ventricular assist device (L-/R-/BVAD, TAH) implantations (n = 942) showed a decrease of 8.2% compared with 2017 (n = 1,027) ([Fig. 9]), while the heart transplantations (n = 312) reached the highest level for the past 5 years ([Fig. 10]). Nevertheless, the mechanical circulatory support therapy, in particular LVAD, is still of outstanding importance for patients with end-stage heart failure.
#
Discussion
The registry of the GSTCVS enables a comprehensive overview of all heart surgical procedures performed in Germany in 2018. The accuracy of this registry is considered to be high due to the implemented compilation algorithm using standardized operation coding as a relevant criterion for reimbursement purposes. This is supported by other authors who could demonstrate a high accuracy for major outcome parameters in unaudited registries.[20] As observed in recent years, heart surgery in Germany is continuously performed on a high level with superior in-hospital patient survival compared with international surveys. In addition, the registry demonstrates that the provision of cardiac surgery in Germany is appropriate, and that patient care is guaranteed nationwide at all times (24/7/365). These aspects are especially important in the context of various activities in health care policy and considering the background of demographic trends of the German population, leading to patients at increased age combined with related comorbidities and an accordingly complex preoperative risk profile.
Compared with 2017, the number of cardiac surgery procedures showed a disproportionate decrease for coronary artery bypass procedures, a curious trend in view of the German population characteristics and in the context of application of the scientific guidelines.[21] [22] Otherwise, the remarkable increase in heart transplantations is a reason for hope that this positive development will continue.
Further improvements of the registry are recommended to enable more specified assessments and particularly risk-adjusted data analyses. However, if significant fundamental changes related to the modality of data collection are conducted, it has to be considered that data compatibility will still allow further longitudinal data analysis.
Completeness, validity, and further progress depend on continued efforts and a close collaboration of the GSTCVS and all cardiac surgical departments in Germany. This will be of outstanding importance as a contribution for patient safety and to obtain evidence for the high quality of heart surgery in Germany.
#
Abbreviations
#
Conflict of Interest
None.
Acknowledgments
The German Society for Thoracic and Cardiovascular Surgery would like to thank all heads of the departments for cardiac surgery in Germany and their employees for their continued cooperation and support to realize the annual update of this registry.
-
References
- 1 Rodewald G, Polonius MJ. Cardiac surgery in the Federal Republic of Germany during 1978 and 1979. Thorac Cardiovasc Surg 1980; 28 (06) 373-377
- 2 Rodewald G, Kalmar P. Cardiac surgery in the Federal Republic of Germany during 1984. Thorac Cardiovasc Surg 1985; 33 (06) 397-399
- 3 Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1988. Thorac Cardiovasc Surg 1989; 37 (03) 193-195
- 4 Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1989. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 1990; 38 (03) 198-200
- 5 Gummert JF, Funkat A, Krian A. Cardiac surgery in Germany during 2004: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2005; 53 (06) 391-399
- 6 Funkat AK, Beckmann A, Lewandowski J. , et al. Cardiac surgery in Germany during 2011: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2012; 60 (06) 371-382
- 7 Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W. German Heart Surgery Report 2017: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2018; 66 (08) 608-621
- 8 Baumgartner H, Falk V, Bax J. , et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38 (36) 2739-2791
- 9 Nishimura RA, Otto CM, Bonow RO. , et al; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (23) e521-e643
- 10 Nishimura RA, Otto CM, Bonow RO. , et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135 (25) e1159-e1195
- 11 Nishimura RA, O'Gara PT, Bavaria JE. , et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: a proposal to optimize care for patients with valvular heart disease. Ann Thorac Surg 2019; 107 (06) 1884-1910
- 12 Richtlinie zu minimalinvasiven Herzklappeninterventionen; Richtlinie über Maßnahmen zur Qualitätssicherung bei der Durchführung von minimalinvasiven Herzklappeninterventionen gemäß § 136 Absatz 1 Satz 1 Nummer 2 für nach § 108 SGB V zugelassene Krankenhäuser MHI-RL; Gemeinsamer Bundesausschuss (G-BA). Available at: https://www.g-ba.de/richtlinien/84/
- 13 Beckmann A, Hamm C, Figulla HR. , et al; GARY Executive Board. The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg 2012; 60 (05) 319-325
- 14 Ensminger S, Fujita B, Bauer T. , et al; GARY Executive Board. Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol 2018; 71 (13) 1417-1428
- 15 Fujita B, Ensminger S, Bauer T. , et al; GARY Executive Board. Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients. Eur J Cardiothorac Surg 2018; 53 (03) 552-559
- 16 Husser O, Fujita B, Hengstenberg C. , et al; GARY Executive Board. Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry. JACC Cardiovasc Interv 2018; 11 (06) 567-578
- 17 Werner N, Zahn R, Beckmann A. , et al. Patients at intermediate surgical risk undergoing interventional or surgical aortic valve implantation for severe aortic stenosis: one year results from the German Aortic Valve Registry. Circulation 2018; 138: 2611-2623
- 18 Bekeredjian R, Szabo G, Balaban Ü. , et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J 2018
- 19 Gammie JS, Zhao Y, Peterson ED, O'Brien SM, Rankin JS, Griffith BP. J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2010; 90 (05) 1401-1408 , 1410.e1, discussion 1408–1410
- 20 Herbert MA, Prince SL, Williams JL, Magee MJ, Mack MJ. Are unaudited records from an outcomes registry database accurate?. Ann Thorac Surg 2004; 77 (06) 1960-1964 , discussion 1964–1965
- 21 Neumann FJ, Sousa-Uva M, Ahlsson A. , et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40 (02) 87-165
- 22 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische KHK – Langfassung, 5 Auflage. Version 1. 2019
Address for correspondence
-
References
- 1 Rodewald G, Polonius MJ. Cardiac surgery in the Federal Republic of Germany during 1978 and 1979. Thorac Cardiovasc Surg 1980; 28 (06) 373-377
- 2 Rodewald G, Kalmar P. Cardiac surgery in the Federal Republic of Germany during 1984. Thorac Cardiovasc Surg 1985; 33 (06) 397-399
- 3 Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1988. Thorac Cardiovasc Surg 1989; 37 (03) 193-195
- 4 Kalmar P, Irrgang E. Cardiac surgery in the Federal Republic of Germany during 1989. A report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 1990; 38 (03) 198-200
- 5 Gummert JF, Funkat A, Krian A. Cardiac surgery in Germany during 2004: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2005; 53 (06) 391-399
- 6 Funkat AK, Beckmann A, Lewandowski J. , et al. Cardiac surgery in Germany during 2011: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2012; 60 (06) 371-382
- 7 Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W. German Heart Surgery Report 2017: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2018; 66 (08) 608-621
- 8 Baumgartner H, Falk V, Bax J. , et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38 (36) 2739-2791
- 9 Nishimura RA, Otto CM, Bonow RO. , et al; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129 (23) e521-e643
- 10 Nishimura RA, Otto CM, Bonow RO. , et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135 (25) e1159-e1195
- 11 Nishimura RA, O'Gara PT, Bavaria JE. , et al. 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: a proposal to optimize care for patients with valvular heart disease. Ann Thorac Surg 2019; 107 (06) 1884-1910
- 12 Richtlinie zu minimalinvasiven Herzklappeninterventionen; Richtlinie über Maßnahmen zur Qualitätssicherung bei der Durchführung von minimalinvasiven Herzklappeninterventionen gemäß § 136 Absatz 1 Satz 1 Nummer 2 für nach § 108 SGB V zugelassene Krankenhäuser MHI-RL; Gemeinsamer Bundesausschuss (G-BA). Available at: https://www.g-ba.de/richtlinien/84/
- 13 Beckmann A, Hamm C, Figulla HR. , et al; GARY Executive Board. The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg 2012; 60 (05) 319-325
- 14 Ensminger S, Fujita B, Bauer T. , et al; GARY Executive Board. Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol 2018; 71 (13) 1417-1428
- 15 Fujita B, Ensminger S, Bauer T. , et al; GARY Executive Board. Trends in practice and outcomes from 2011 to 2015 for surgical aortic valve replacement: an update from the German Aortic Valve Registry on 42 776 patients. Eur J Cardiothorac Surg 2018; 53 (03) 552-559
- 16 Husser O, Fujita B, Hengstenberg C. , et al; GARY Executive Board. Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry. JACC Cardiovasc Interv 2018; 11 (06) 567-578
- 17 Werner N, Zahn R, Beckmann A. , et al. Patients at intermediate surgical risk undergoing interventional or surgical aortic valve implantation for severe aortic stenosis: one year results from the German Aortic Valve Registry. Circulation 2018; 138: 2611-2623
- 18 Bekeredjian R, Szabo G, Balaban Ü. , et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J 2018
- 19 Gammie JS, Zhao Y, Peterson ED, O'Brien SM, Rankin JS, Griffith BP. J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2010; 90 (05) 1401-1408 , 1410.e1, discussion 1408–1410
- 20 Herbert MA, Prince SL, Williams JL, Magee MJ, Mack MJ. Are unaudited records from an outcomes registry database accurate?. Ann Thorac Surg 2004; 77 (06) 1960-1964 , discussion 1964–1965
- 21 Neumann FJ, Sousa-Uva M, Ahlsson A. , et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40 (02) 87-165
- 22 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronische KHK – Langfassung, 5 Auflage. Version 1. 2019